GSK Novartis Asset Swap to be Completed Next Week

Source: Reuters

Feb 26, 2015

GlaxoSmithKline announced it expects to conclude its $20 billion-plus three-part asset swap with Novartis next week.

In April of last year, GSK announced it would be creating a new Consumer Health Care business through a joint venture that will combine Novartis’ over-the-counter drug business with GSK’s consumer business. Novartis will own 36.5% of the new "GSK Consumer Healthcare" venture, leaving GSK with 63.5% and managerial control.

GlaxoSmithKline also recently announced that its chairman-designate Philip Hampton will take charge in May, replacing Chris Gent, who has chaired GSK since 2005.

Read the Reuters press release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments